Pacific Edge shares gain 4% on fourth US deal

Pacific Edge shares gain 4% on fourth US deal
By Suze Metherell May. 26 (BusinessDesk) - Shares in Pacific Edge gained 4 percent after the biotech company said it had signed a deal with US healthcare provider MultiPlan for the use of its non-invasive bladder cancer test, Cxbladder. The contract is the largest of the four US healthcare provider Pacific Edge has signed up since October last year, with MultiPlan a preferred provider organisation securing cheaper health rates for insurers for more than 900,000 healthcare providers covering an estimated 68 million people. Its previous thr...